Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04187950
Other study ID # 20121
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 19, 2021
Est. completion date November 2, 2022

Study information

Verified date July 2023
Source University of Illinois at Urbana-Champaign
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to test the central hypothesis that adding to the diet daily yogurt with honey provides beneficial effects on digestive health and subjective mood in healthy adults.


Description:

This clinical trial will be a randomized, controlled, double-blind, crossover study with two 2-week treatment conditions separated by at least a 4-week washout period between conditions. Participant flow through the study conditions will be counterbalanced. Participants will be randomly allocated to yogurt with honey first or control first. Before beginning the first intervention period, participants will undergo a 2-week lead-in period that is devoid of all supplemental and dietary probiotics, fermented dairy products, and fermented foods. Participants will be asked to refrain from consuming all supplemental and dietary probiotics, fermented dairy products, and fermented foods throughout the entire study.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date November 2, 2022
Est. primary completion date November 2, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years to 64 Years
Eligibility Inclusion Criteria: - Males and females - Between the ages of 22-64 years at the time of consent - Body mass index of 18.5 to 29.9 kg/m^2. - Normal or corrected-to-normal vision based on the minimal 20/20 standard in order to complete the cognitive task (below 20/20 vision). - Ability to drop off fecal sample within 30 minutes of defecation - Have between 3-6 bowel movements per week Exclusion Criteria: - Current pregnancy, lactation, or post-menopausal - Tobacco use - Honey allergy or intolerance - Dairy allergy, lactose intolerance - Food dye allergy/intolerance - Prior physician diagnosed gastrointestinal disease (chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers, hepatitis, or gastroesophageal reflux disease (GERD)) - Current use or use of antibiotics in the past 3 months - Current use of any of the following types of medications: laxatives, anti-diarrhea medications, narcotics, enemas, antispasmodics, anticonvulsants, prescription proton pump inhibitors, prokinetic agents, histamine-2 Rc antagonists (prescription GERD medication) - Body mass index > 29.9 kg/m^2 - Prior malabsorptive bariatric surgery (i.e. gastric bypass, sleeve gastrectomy) - Restrictive bariatric surgery (i.e. adjustable gastric band) within the past 5 years - Concurrent enrollment in another dietary, exercise, or medication study

Study Design


Intervention

Dietary Supplement:
Yogurt with B. lactis and added honey
The intervention condition will utilize a commercially available yogurt (Activia) that contains Bifidobacterium animalis lactis DN-173 010/CNCM I-2494 (B. lactis). Participants will consume 170 g of yogurt with honey twice daily for 14 days.
Yogurt with heat-inactivated B. lactis and added cane sugar
The control condition will utilize a commercially available yogurt (Activia) following heat inactivation of the probiotic Bifidobacterium animalis lactis DN-173 010/CNCM I-2494 (B. lactis). Participants will consume 170 g of the heat-inactivated yogurt with added cane sugar twice daily for 14 days.The added cane sugar will be an isocaloric amount to the honey.

Locations

Country Name City State
United States University of Illinois at Urbana-Champaign Urbana Illinois

Sponsors (2)

Lead Sponsor Collaborator
University of Illinois at Urbana-Champaign National Honey Board

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intestinal transit time measured using colored dye markers Determine the impact of consumption of daily yogurt with honey on intestinal transit time in vivo compared to control, yogurt containing heat-inactivated B.lactis with added sugar. Intestinal transit time will be measured using colored dye markers. 2 weeks
Secondary Digestive health measured using daily stool records with the Bristol Stool Scale Determine the impact of consumption of daily yogurt with honey on digestive health compared to control (yogurt containing heat-inactivated B. lactis) using daily stool records. Within the records, participants rate stool consistency using the Bristol Stool Scale. 2 weeks
Secondary Digestive health measured using rating scales of additional symptoms in daily stool records Determine the impact of consumption of daily yogurt with honey on other measures of digestive health compared to control (yogurt containing heat-inactivated B. lactis) using daily stool records. Within the records, ratings of additional gastrointestinal symptoms include ease of passage, abdominal pain, bloating, burping, flatulence, nausea, reflux, and rumblings. 2 weeks
Secondary Digestive health measured using the Gastrointestinal Tolerability questionnaire Determine the impact of consumption of daily yogurt with honey on other measures of digestive health compared to control (yogurt containing heat-inactivated B. lactis) using the Gastrointestinal Tolerability questionnaire. This questionnaire assesses gastrointestinal health through 6 questions related to gastrointestinal health including nausea, bloating, rumblings, gas/flatulence, abdominal pain, and diarrhea. Each of the questions pertains to experience of symptoms in the past 7 days. 2 weeks
Secondary Digestive health measured using the Gastrointestinal Quality of Life Index (GIQLI) questionnaire Determine the impact of consumption of daily yogurt with honey on other measures of digestive health compared to control (yogurt containing heat-inactivated B. lactis) using the Gastrointestinal Quality of Life Index (GIQLI) questionnaire. The GIQLI assesses gastrointestinal health through a series of 36 questions pertaining to daily life and gastrointestinal symptoms experienced in the past 2 weeks. 2 weeks
Secondary Mood measured using the Emotional Image Task Determine the impact of consumption of daily yogurt with honey on mood states compared to control (yogurt containing heat-inactivated B. lactis) using the Emotional Image Task. This task measures response to neutral, positive, and negative image stimuli using participant valence, arousal, and dominance ratings. 2 weeks
Secondary Mood measured using the Positive and Negative Affect Schedule (PANAS) questionnaire Determine the impact of consumption of daily yogurt with honey on mood states compared to control (yogurt containing heat-inactivated B. lactis) using the Positive and Negative Affect Schedule (PANAS) questionnaire. The PANAS assesses general mood using a 20-item scale that includes words associated with either positive (10 words) or negative (10 words) emotions. 2 weeks
Secondary Mood measured using the Depression, Anxiety, and Stress Scales-42 (DASS-42) questionnaire Determine the impact of consumption of daily yogurt with honey on mood states compared to control (yogurt containing heat-inactivated B. lactis) using the Depression, Anxiety, and Stress Scales-42 (DASS-42) questionnaire. The DASS-42 includes subscales with 42 questions regarding negative emotional states and is used to assess mental health over the past week. 2 weeks
Secondary Mood measured using Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaires Determine the impact of consumption of daily yogurt with honey on mood states compared to control (yogurt containing heat-inactivated B. lactis) using Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaires. Specific PROMIS questionnaires utilized included PROMIS SF v1.0 - Anger 8a, PROMIS SF v1.0 - Anxiety 8a, PROMIS SF v1.0 - Fatigue 8a, PROMIS SF v1.0 - Positive Affect 15a, PROMIS SF v1.0 - Self-Efficacy Manage Emotions 8a, PROMIS SF v1.0 - Fatigue 13a (FACIT-Fatigue), PROMIS SF v1.1 - Global Health, and PROMIS SF v2.0 - Cognitive Function 8a. PROMIS. Surveys were scored using the recommended HealthMeasures Scoring Service. 2 weeks
Secondary Cognitive function assessed using the Spatial Reconstruction Task Determine the impact of consumption of daily yogurt with honey on cognitive function compared to control (yogurt containing heat-inactivated B. lactis) using the Spatial Reconstruction Task. This task requires participants to successfully encode and retrieve information pertaining to the position of six objects in relation to each other, necessitating recruitment of the hippocampal memory system. 2 weeks
Secondary Gastrointestinal microbiota assessed using relative abundances Determine the impact of daily consumption of yogurt with honey on the gastrointestinal microbiota compared to control (yogurt containing heat-inactivated B. lactis). Relative abundances of the gastrointestinal microbiota will be measured with 16S amplicon sequencing. 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT04901390 - Impact of Yogurt on Gastrointestinal Health, Regularity, and Thoughts N/A
Completed NCT04560595 - Remote Guided Caffeine Reduction N/A
Not yet recruiting NCT05566171 - The Effect of Probiotic Supported Yogurt Consumption on Gastrointestinal Symptoms N/A
Completed NCT04979494 - Association Between SMA Flow and AGI in Critically Ill Patients
Completed NCT04005456 - Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design N/A
Withdrawn NCT02574611 - Use of High Resolution Colonic Manometry in Studying Motility Phase 1
Recruiting NCT04112056 - Post-market Surveillance Study of an Infant Formula Containing Moderately Hydrolyzed Protein and Low Lactose N/A
Completed NCT05765123 - Gastric Emptying Validation Pilot Study (MRI Val)
Active, not recruiting NCT05750433 - Phage 3Determination of Phage/Probiotic Synergistic Effects on Gastrointestinal Health N/A
Not yet recruiting NCT06128785 - Electroacupuncture (EA) Promotes Gastrointestinal Functional Recovery After Radical Colorectal Cancer Surgery N/A
Not yet recruiting NCT04647201 - Study of Biomarkers in Patients of Sepsis Complicated With Gastrointestinal Dysfunction
Completed NCT01828047 - Sublingual Microcirculation and Postoperative Ileus N/A
Completed NCT05309837 - Effect of Polydextrose on Fecal Bulk and Bowel Function in Mildly Constipated Subjects N/A
Not yet recruiting NCT06088940 - The Chemo-Gut Probiotic Trial for Cancer Survivors N/A
Not yet recruiting NCT06376461 - Prospective, Multicentre Study to Validate the GastroIntestinal Dysfunction Score (GIDS) and Describe Prevalence, Outcomes, and Management of Phosphate Disorders in Intensive Care Patients
Completed NCT02486328 - The Effect of Different Sedation Regimes on Cognitive Function in Lower Gastrointestinal System Endoscopy Phase 4
Recruiting NCT05669612 - Promephy - Metabolic Fate of Plant-based Proteins N/A
Active, not recruiting NCT05418127 - An Efficacy Trial in the Research Area of Gastrointestinal Health & Bloating N/A
Completed NCT04606485 - Does Acupressure Affect Gastrointestinal Function, Pain and Anxiety? N/A
Recruiting NCT06386471 - Personalized GI Motility Responses to Diet N/A